Implementation of the tool ensured the monitoring of critical laboratory parameters such as MetHb and Hb levels for patients on dapsone, a drug known to cause hemolytic anemia and methemoglobinemia [9], and of hepatic transaminases for all patients on rifampin, a known hepatotoxin [9]. Here, GSTM1 is linked to methemoglobinemia.